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Objective: Although malignant pleural effusion or dissemination is regarded as T4 per TNM classification of
lung cancer, the prognostic significance in staging of pleural lavage cytologic examination remains undetermined.
The purpose of this study was to clarify the utility of pleural lavage cytologic staging as a prognostic factor in
patients with non–small cell lung cancer.
Methods: In 1271 patients with lung cancer who underwent curative resection, intraoperative pleural lavage cyto-
logic examinationwas performed at thoracotomy (first cytologic examination), immediately after pulmonary resec-
tion andmediastinal lymph node dissection (second cytologic examination), and after last washing of pleural cavity
(third cytologic examination). Positive first cytologic result represented cytologic positive result before lung resec-
tion; positive second and third cytologic results were regarded as cytologic positive results after lung resection.
Results: Eighty-nine patients (7.0%) had positive findings of pleural lavage cytologic examination before or after
lung resection. Five-year survivals were 44.1% for patients with positive results before lung resection and 23.4%
for patients with positive results after lung resection, both significantly worse than that for patients with negative
results. Multivariate analyses revealed that positive lavage result after lung resection was an independent prog-
nostic factor. We found significantly greater pleural recurrence among patients with positive pleural lavage
cytologic results after lung resection than among those with negative results.
Conclusions: In addition to TNM classification, results of pleural lavage cytologic examination after lung resec-
tion should be considered when staging non–small cell lung cancer. Adjuvant systemic therapy may improve out-
come for patients with positive results.Earn CME credits at
http://cme.ctsnetjournals.org
Intraoperative pleural lavage cytologic examination (PLC)
has been suggested as a possible prognostic factor for
patients with non–small cell lung cancer (NSCLC).1-7 Al-
though there have been differences in the timing of instilla-
tion, volume, and type of carrier solution, a consistent
finding is the uniformly poor prognosis of patients with pos-
itive results.8 We performed intraoperative PLC on more
than 1200 patients at the same institution since 1985 and an-
alyzed the relationship between positive cytologic findings
and several pathologic factors. Malignant pleural effusion
or pleural dissemination is regarded as T4 according to the
TNM classification9; however, the prognostic significance
of PLC remains undetermined in terms of staging. The aim
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factor for patients with NSCLC.
MATERIALS AND METHODS
From September 1985 to December 2005 in our institution, thoracotomy
was performed in 1490 patients with pathologic stage IA to IIIA NSCLC.
Because we excluded patients with effusion at the time of the operation, ex-
treme adhesions, extreme chest wall invasion, or lack of curative resection,
this study consisted of 1271 patients with lung cancer. All patients under-
went intraoperative PLC at three times as previously reported4: (1) at thora-
cotomy immediately on entering the pleural space (1st PLC), (2) at
thoracotomy on completion of pulmonary resection and mediastinal lymph
nodes (2nd PLC), and (3) at thoracotomy after the last washing of the pleural
cavity with 5000mL physiological saline solution before closing (3rd PLC).
At each lavage, the pleural cavity was filled with 500 mL physiologic saline
solution, which was aspirated into a glass bottle with heparin. About 400mL
of the supernatant of the lavage fluid was discarded after settlement, and the
remainder was centrifuged at 1500 rpm for 5 minutes. Cytologic examina-
tion was performed with the Papanicolaou method. Papanicolaou classes IV
and V were regarded as positive cytologic findings.
Pathologic staging was assessed according to TNM staging (Interna-
tional Union Against Cancer),9 and the histologic type of the tumor was
assessed according to the World Health Organization classification.10 Path-
ologic TNM classification, pleural status, differences in histologic type, and
lymphatic and vascular invasions were examined. The Japanese Lung Can-
cer Society11 guidelines were used to classify pleural status into four groups
as follows: p0, visceral pleura is not invaded by the tumor; p1, tumor has
reached but not invaded through the visceral pleura; p2, tumor has invaded
the visceral pleura but has not involved the parietal pleura; and p3, tumor has
invaded the parietal pleura and chest wall.
Survival was defined as the interval in months between the day of oper-
ation and the date of death from any cause or of the last follow-up. Cancer
recurrence was divided into three categories according to the sites of initialardiovascular Surgery c Volume 137, Number 4 835
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recurrence: locoregional, pleural, and distant. Pleural recurrence was
defined as any recurrent disease within the hemithoracic pleura.
An institutional review board approved this retrospective study, andwrit-
ten informed consent for the surgical intervention was obtained from each
patient. The c2 test was used to assess the statistical significance of the dif-
ferences according to PLC status and clinicopathologic factors. Survival
curves were calculated according to the method of Kaplan and Meier,12
and the log-rank test was used to compare the survival curves. Variables re-
lated to survival were analyzedwith the Cox proportional hazards regression
model13 (StatView version 5.0; SAS Institute, Inc, Cary, NC).
RESULTS
Patient clinicopathologic characteristics are shown in
Table 1. The median follow-up was 5.7 years. Eighty-nine
patients, 7.0% of the study group (n ¼ 1271), had positive
findings on PLC before or after lung resection. As shown
in Table 2, 67 patients (5.3%) had positive PLC results at
thoracotomy (1st PLC). Thirty-two patients (2.5%) had pos-
itive results at thoracotomy on completion of pulmonary
resection and mediastinal lymph nodes (2nd PLC), at thora-
cotomy after the last washing of the pleural cavity before
closing (3rd PLC), or both. Positive 1st PLC result was re-
garded as a positive PLC result before lung resection,
whereas positive 2nd and 3rd PLC results were regarded as
positive PLC results after lung resection. Ten patients had
positive PLC results both before and after lung resection.
There were significant differences between patients with
negative and positive PLC results before lung resection in
pathologic stage, pleural invasion, T status, and vascular in-
vasion (Table 3). Furthermore, significant differences were
observed between patients with negative and positive PLC
results after lung resection in pathologic stage, T status,
and vascular invasion (Table 4). The 5-year survivals were
44.1% (95% confidence interval [CI] 31.2%–57.0%) for
patients with positive PLC results before lung resection
and 21.9% (95% CI 7.6%–34.2%) for patients with posi-
tive PLC results after lung resection, both of which were sig-
nificantly worse than the 58.3% (95% CI 55.2%–61.4%)
survival for patients with negative PLC results (Figures 1
and 2). To evaluate PLC result as a prognostic factor, multi-
variate analyses were performed with variables regarded as
clinical prognostic factors for patients with NSCLC. These
analyses revealed that a positive PLC result after lung resec-
tion was an independent prognostic factor (Table 5). Age,
pathologic stage, lymphatic invasion, and vascular invasion
were also independent prognostic factors.
We found recurrences in 384 of 1182 patients (32.5%)
with negative PLC results, in 32 of 67 patients (47.8%)836 The Journal of Thoracic and Cardiovascular Suwith positive PLC results before lung resection, and in 20
of 32 patients (62.5%) with positive PLC results after
lung resection. The 5-year disease-free survivals were
36.9% (95% CI 22.2%–51.6%) for patients with positive
PLC results before lung resection, 34.1% (95% CI
14.3%–54.9%) for patients with positive PLC results after
lung resection, and 38.1% (95% CI 34.0%–42.2%) for pa-
tients with negative PLC results. There was no significant
difference among these survivals. Recurrence patterns
among patients with positive PLC results are shown in Table
6. We found a significantly higher rate of pleural recurrence
in patients with positive PLC results after lung resection than
among with those with negative PLC results.
DISCUSSION
The survival in the group with positive PLC results was
significantly lower than that in the group with negative
PLC results, indicating that intraoperative PLC is a useful
technique for estimating the prognosis of patients with
lung cancer, as has been previously suggested.1-7,14 In agree-
ment with the findings of Enatsu and colleagues,15 positive
PLC results after lung resection had a greater impact on
TABLE 1. Patient characteristics (n ¼ 1271)
Characteristic No.
Sex
Male 870
Female 401
Pathologic stage
IA 393
IB 335
IIA 44
IIB 232
IIIA 267
Histologic type
Adenocarcinoma 699
Squamous cell carcinoma 398
Others 174
TABLE 2. Results of pleural lavage cytologic examination
Cytologic examination Results
1st
PLC
2nd
PLC
3rd
PLC
Total
patients
Before
resection
After
resection
Negative Negative Negative 1182 Negative Negative
Positive Negative Negative 57 Positive Negative
Positive Negative Positive 2 Positive Positive
Positive Positive Negative 4 Positive Positive
Positive Positive Positive 4 Positive Positive
Negative Negative Positive 4 Negative Positive
Negative Positive Negative 13 Negative Positive
Negative Positive Positive 5 Negative Positive
PLC, Pleural lavage cytologic result; 1st PLC, at thoracotomy immediately on entering
pleural space; 2nd PLC, after completion of pulmonary resection and mediastinal
lymph node dissection; 3rd PLC, after last washing of pleural cavity before closing.rgery c April 2009
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Multivariate analyses also revealed that a positive PLC re-
sult after lung resection as an independent prognostic factor
was as significant as established prognostic factors, includ-
ing T status and N status. The 5-year survival after surgery
was 23.4% for patients with positive PLC results after
lung resection, whereas the 5-year survivals for patients
with stages IIIA and IIIB were 31.4% and 21.7%, respec-
tively. Kotoulas and associates16 reported that a positive
PLC result after lung resection is a T4 element, upgrading
the stage to IIIB. Thus PLC after lung resection as an addi-
tion to the TNM classification is recommended to help deter-
mine the prognosis of patients with NSCLC.
Buhr and colleagues3 reported that pleural lavage was
done before lung resection to determine whether tumor cells
were disseminated into the pleural cavity.3 Exfoliation of tu-
TABLE 3. Clinicopathologic characteristics of patients with positive
results of pleural lavage cytologic examination before lung resection
Factor
Positive
(n ¼ 67)
Negative
(n ¼ 1204)
Total
(n ¼ 1271)
P
value
Sex .2969
Male 42 (4.8%) 828 870
Female 25 (6.2%) 376 401
Pathologic stage .0397
I 29 (4.0%) 699 728
II 17 (6.2%) 259 276
IIIA 21 (7.9%) 246 267
Histologic type .1408
Adenocarcinoma 44 (6.3%) 655 699
Squamous cell
carcinoma
14 (3.5%) 384 398
Other 9 (5.2%) 165 174
Pathologic pleural
involvement
<.0001
p0 26 (3.4%) 731 757
p1 10 (4.5%) 212 222
p2 18 (14.7%) 105 123
p3 13 (7.7%) 156 169
Pathologic T status .0002
T1 10 (2.1%) 469 479
T2 43 (6.8%) 592 635
T3 14 (8.9%) 143 157
Pathologic N status .0937
N0 36 (4.5%) 772 808
N1 13 (5.4%) 229 242
N2 18 (8.1%) 203 221
Lymphatic invasion
(n ¼ 1192)
.1751
Positive 42 (6.0%) 655 697
Negative 21 (4.2%) 474 495
Vascular invasion
(n ¼ 1193)
.0048
Positive 47 (6.9%) 639 686
Negative 16 (3.2%) 491 507
Values represent numbers of patients.The Journal of Thoracic and Cmor cells through subpleural lymphatics and vessels to the
pleural space has been reported to be a cause of positive
PLC results before lung resection.5,7 There was a significant
relationship between positive PLC results before lung resec-
tion and pleural invasion, making PLC at thoracotomy use-
ful for estimation of pleural invasion. Similarly to the
findings of Nakagawa and associates,14 p2 was more fre-
quently observed than p3 in patients with positive PLC re-
sults before lung resection, suggesting that tumor that has
reached but not invaded through the visceral pleura is impor-
tant for cancer cells to desquamate into the pleural space. In
our study, 32 of 67 patients (47.8%) with positive PLC re-
sults before lung resection had recurrence, and 3 of these
(9%) had carcinomatous pleuritis, a higher rate of recur-
rence in the pleural cavity than was seen among patients
with negative PLC results (2%).
TABLE 4. Clinicopathologic characteristics for patients with positive
results of pleural lavage cytologic examination after lung resection
Factor
Positive
(n ¼ 32)
Negative
(n ¼ 1239)
Total
(n ¼ 1271)
P
value
Sex .6728
Male 23 (2.6%) 847 870
Female 9 (2.2%) 392 401
Pathologic stage .6991
I 16 (2.2%) 712 728
II 8 (2.9%) 268 276
IIIA 8 (3.0%) 259 267
Histologic type .9785
Adenocarcinoma 18 (2.6%) 681 699
Squamous cell
carcinoma
10 (2.5%) 388 398
Other 4 (2.3%) 170 174
Pathologic pleural
involvement
.1674
p0 14 (1.8%) 743 757
p1 6 (2.7%) 216 222
p2 4 (3.3%) 119 123
p3 8 (4.7%) 161 169
Pathologic T status .0016
T1 3 (0.6%) 476 479
T2 21 (3.3%) 614 635
T3 8 (5.1%) 149 157
Pathologic N status .6299
N0 18 (2.2%) 790 808
N1 8 (3.3%) 234 242
N2 6 (2.7%) 215 221
Lymphatic invasion
(n ¼ 1192)
.2886
Positive 21 (3.0%) 676 697
Negative 10 (2.0%) 485 495
Vascular invasion
(n ¼ 1193)
.0468
Positive 24 (3.5%) 662 686
Negative 7 (1.4%) 500 507ardiovascular Surgery c Volume 137, Number 4 837
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section indicated whether surgical manipulation had led to
exfoliation of tumor cells into the pleural cavity. Kotoulas
and associates16 reported that the main causes of positive
PLC results after lung resection are the exfoliation of cancer
cells into the pleural cavity from infiltrated mediastinal
lymph nodes and the spreading of the cancer cells of infil-
trated mediastinal lymph nodes as a result of surgical manip-
ulations during the mediastinal dissections. We also found
significant differences in pathologic stage, T status, and vas-
cular invasion between patients with positive and negative
PLC results after lung resection, indicating that surgical ma-
nipulation of a large tumor with vessel invasion might lead
to exfoliation and release of cancer cells into the pleural cav-
FIGURE 1. Survival curves for patients with positive versus negative
results of pleural lavage cytologic examination before lung resection.
FIGURE 2. Survival curves for patients with positive versus negative re-
sults of pleural lavage cytologic examination after lung resection.838 The Journal of Thoracic and Cardiovascular Suity. Thirty-two patients showed positive PLC results after re-
section of lung andmediastinal lymph nodes; 17 of these had
negative results after the last washing of the pleural cavity,
whereas the remaining 15 patients showed positive PLC re-
sults even after the last washing (Table 2). The 5-year sur-
vivals were 29.4% for patients with positive PLC results
before the last washing and 15.2% for patients with positive
PLC results after the last washing. The frequency of recur-
rence in the pleura was greater among patients with positive
PLC results after lung resection than in other groups. These
data suggest that a positive PLC result after lung resection is
indicative of cancer cells in the pleural cavity, which in turn
may result in local recurrence at pleura.
The JapaneseClinical OncologyGroup17 conducted a ran-
domized trial to determine the efficacy of intraoperative in-
trapleural hypotonic cisplatin treatment for patients with
positive PLC results. Survivals were not significantly differ-
ent between the treated and control groups. Satoh and col-
leagues18 analyzed recurrence patterns in patients with
positive PLC results and reported that 72% had distant me-
tastasis.18 We found distant metastasis in 36 of patients with
TABLE 5. Multivariate analysis of potential prognostic factors
Variable
Hazard
ratio
95% Confidence
interval
P
value
Age
65 y vs<65 y 1.895 1.592–2.256 <.0001
Pathologic stage
IIIA vs I 2.438 1.969–3.019 <.0001
II vs I 1.626 1.305–2.027 <.0001
Histologic type
Other vs adenocarcinoma
or squamous
1.113 0.936–1.323 .2245
Lymphatic invasion
Positive vs negative 1.270 1.041–1.551) .0188
Vascular invasion
Positive vs negative 1.562 1.269–1.921 <.0001
PLC before resection
Positive vs negative 1.072 0.753–1.525 .7003
PLC after resection
Positive vs negative 2.313 1.516–3.531 .0001
PLC, Pleural lavage cytologic result.
TABLE 6. Recurrence of disease in patients with positive and negative
results of pleural lavage cytologic examination
Positive
Recurrence
Before resection
(n ¼ 67)
After resection
(n ¼ 32)
Negative
(n ¼ 1182)
Total 32 20 384
Pleural 3 (9%) 5 (25%) 7 (2%)
Distant 24 (75%) 11 (55%) 324 (84%)
Locoregional 5 (16%) 4 (20%) 53 (14%)
By c2 test, P< .05 for positive results before resection versus negative results and
P< .0001 for positive results after resection versus negative results.rgery c April 2009
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ing that a positive PLC result is a sign of systemic disease.
Therefore curative resection followed by adjuvant systemic
therapy may be necessary to improve outcome for patients
with positive PLC results. Furthermore, we should verify in-
traoperative intrapleural treatment for patients with NSCLC
who have positive PLC results after lung resection to reduce
the rate of pleural recurrence.
In conclusion, we have shown that a positive PLC result
after lung resection can be used as an independent prognos-
tic factor for staging NSCLC, together with such established
prognostic factors as pathologic T status and N status. In
addition adjuvant systemic therapy may be necessary to
improve outcome for patients with positive PLC results.
We thank Margaret J. Wheelock (University of Nebraska Med-
ical Center) for reviewing this article.
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